Lori Geissler

The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.

A. Dallob, Neil S. Sadick, Walter Unger et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 197 citations

Medicine, Endocrinology, Pharmacology +17

The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia

Lynn A. Drake, Maria Hordinsky, Virginia C. Fiedler et al. · Journal of the American Academy of Dermatology · 1999 · 182 citations

Medicine, Dermatology, Endocrinology +15

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

Gary Herman, Meagan P. O’Brien, Eduardo Forleo‐Neto et al. · The Lancet Infectious Diseases · 2022 · 41 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +8

MK-386, an Inhibitor of 5α-Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum without Affecting Dihydrotestosterone Concentrations in Semen¹

Jules I. Schwartz, Wesley Tanaka, Daniel Z. Wang et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 37 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

MK-386, an Inhibitor of 5 alpha-Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum Without Affecting Dihydrotestosterone Concentrations in Semen

Jules I. Schwartz, Wesley Tanaka, Daniel Z. Wang et al. · Obstetrical & Gynecological Survey · 1997 · 12 citations

Life Sciences, Biochemistry, Endocrinology +6